识别选择性ATP-竞争性CMG酶抑制剂用于癌症干预,破坏CMG-复原体功能
Shengyan Xiang1,2, Xingju Luo1,2, Darcy Welch1,3
1Cancer Biology and Evolution Program, Moffitt Cancer Center and Research Institute, Tampa, FL 33612.
Research square
|August 23, 2023
概括
研究人员发现了新型的CMG酶抑制剂 (CMGi),可以选择性地向癌细胞. 这些化合物通过抑制CMG ATPase和酶活动来破坏DNA复制和细胞生长,提供了一种新的抗癌治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 由于瘤特异性脆弱性,CMG螺旋酶 (Cdc45-MCM-GINS) 对于DNA复制至关重要,并具有潜在的抗癌标.
- 瘤变化和复制性压力 (例如,化疗) 强调了CMG在癌细胞存活和恢复中的重要作用.
结论:
- CMGi通过破坏复制体完整性和与关键复制因子的相互作用来诱导DNA损伤.
- 这些新型CMGi对瘤细胞具有选择性毒性.
- 定义了一个新的CMG基酶向抗癌化合物类别,具有独特的作用机制.
关键词:
在CMG中使用 CMG Helicase.Cdc4545 在线播放复制DNA复制DNA复制DNA复制吉恩斯 (GINS) 公司这是一个MCMM,MCMM是MCMM.氨基库马林是一种氨基库马林.更多相关视频
10:11Author Spotlight: Investigating the Motion Dynamics of the Eukaryotic Replisome Components at the Single-Molecule Level
Published on: July 26, 2024
1.1K
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.1K
相关概念视频
DNA Helicases
21.5K
DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
21.5K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K
